Retinoic acid (RA)-induced differentiation of human teratocarcinoma (T2) cells results in a change from a normally non-permissive phenotype for human cytomegalovirus (HCMV) infection to cells which are fully permissive. We have used this system to analyse factors associated with differentiation which may regulate HCMV gene expression. Differentiation of T2 cells results in an increase of c-ras expression. Consequently, we have introduced ras expression vectors into T2 cells. We find that, as with RA induction, transfection ofT2 cells with oncogenic human Ha-ras results in cells which are permissive for HCMV infection and gene expression. However, unlike RA which induces a cessation of cell proliferation and terminal differentiation, ras transfection only appears to result in changes associated with early events in RA-induced differentiation of T2 cells.
INTRODUCTION
Pluripotent embryonal carcinoma cell lines which differentiate in response to retinoic acid (RA) serve as a useful model system to study factors associated with differentiation that also regulate viral gene expression. Murine embryonal carcinoma cells are resistant to infection by retroviruses but this restriction is lifted if cells are allowed to differentiate (Swartzendruber & Lehman, 1975) . A similar phenomenon has been reported involving human cytomegalovirus (HCMV) and undifferentiated human embryonic carcinoma cells (Gonczol et at., 1984) .
Human cytomegalovirus is a human herpesvirus and exhibits temporally ordered gene expression. Three broad classes of HCMV gene expression have been defined: immediate early (IE), early and late (Honess & Roizman, 1974) and, similarly to herpes simplex virus, the IE genes of HCMV are believed to play a key role in controlling later viral functions (Hermiston et al., 1987) . That human teratocarcinoma (T2) cells are non-permissive for HCMV infection and replication is probably due to a block in viral IE gene expression (Nelson & Groudine, 1986; LaFemina & Hayward, 1986) . However, RA-induced differentiation lifts this expression permitting IE gene expression and viral DNA replication (Gonczol et al., 1984) . We have used this system to study factors associated with differentiation which may regulate virus gene expression. We have asked whether changes in cellular oncogene (c-onc) expression accompany RA-induced differentiation of human embryonal carcinoma cells and whether expression of exogenous oncogenes in these cells can alter their state of differentiation and modify their level of permissiveness for infection with HCMV. Here we show that the steady state levels of c-ras increase in T2 cells upon RA-induced differentiation and that expressior~ of exogenous oncogenic human Ha-ras in T2 ceils, while resulting in permissiveness for HCMV infection and changes in cell surface antigens seen at early times in RA-induced differentiation, does not induce full terminal differentiation which is a long-term effect of induction of T2 cells with RA. 
METHODS
Cell culture. The human teratocarcinoma cell line NT2DI (a gift from Dr P. GoodfeUow, Imperial Cancer Research Fund, London, U.K.) was maintained in Dulbecco's modified Eagle's medium supplemented with 10% foetal calf serum. Cell cultures were split 1:3 every 4 days.
RNA analysis. Total cellular RNA was isolated from cells by guanidinium isothiocyanate-CsCl gradients (Maniatis et al., 1982) . RNA was slot-blotted on nitrocellulose and hybridized in 50% formamide, 9% dextran sulphate for 36 to 48 h at 42°C to a v-Ha-ras-specific probe from Harvey marine sarcoma virus or a probe to yactin.
Plasmids and DNA transfection. Approximately 5 x 106 cells were transfected with 5 l~g of the dominant selectable marker pSV2neo (Southern & Berg, 1982) together with 15 ktg of pEJ6.6 (Shih & Weinberg, 1982) , a genomic human Ha-ras clone from T24 bladder carcinoma cells, by calcium phosphate coprecipitation. Cells were selected in 500 ~tg/ml G-418 (Gibco) 48 h post-transfection. At 21 to 28 days post-selection colonies were pooled and analysed.
Immunafluorescence. Cells were grown overnight on spot slides, rinsed in phosphate-buffered saline (PBS) and fixed for 3 min in acetone :methanol (1:1) at -2 0 °C. For staining of the differentiation-specific cell surface antigen SSEA1, cells were fixed in 5~o formaldehyde, 2% sucrose in PBS for 10 min at room temperature. Spot slides were then incubated with monoclonal (diluted 1 : 100) or polyclonal (undiluted) antibodies for 1 h at room temperature. After washing with PBS the bound polyclonal antibodies were detected with fluorescein-conjugated goat anti-sheep immunoglobulin (diluted l : 20) and bound monoclonal antibodies were detected with fluoresceinconjugated rabbit anti-mouse immunoglobulin (diluted 1 : 30). SSEA 1 monoclonal antibody binding was detected with fluorescein-conjugated rabbit anti-mouse IgM (Sigma) diluted 1 : 100. Fluorescein was detected with n.y. illumination.
The monoclonal antibodies for SSEAI and SSEA3 were from Dr P. Goodfellow, the L14 monoclonal antibody was a gift from Dr J. Nelson (Scripps Institute, La Jolla, Ca., U.S.A.) and the polyclonal antibody to H-ras Valx2 was purchased from Cetus.
CA T assays.
Approximately 5 x 106 stably transfected cell lines or control cells were retransfected by calcium phosphate coprecipitation with 100 ng of pEScat, containing a chloramphenicol acetyltransferase (CAT) gene under the control of 2.1 kb of 5' non-coding region of the HCMV major IE gene constructed by insertion of a SacI fragment from the vector pIElcat term (G. Wilkinson & A. Akrigg, unpublished data; Sinclair, 1987) into a SacI deletion of pES (Boom et al., 1986) and analysed 48 h later for CAT activity (Gorman et al., 1982) . For transient transfections, NT2DI cells were transfected with 100 ng of pEScat together with 5 ~tg of pBR322 or 5 ttg of pEJ6.6 and analysed 48 h post-infection for CAT activity, pIEPlcat term (Sinclair, 1987) , an IE-cat expression vector under control of 302 bp of 5' non-coding region of the major IE gene, was a generous gift of Drs G. Wilkinson and A. Akrigg (PHLS, Porton Down, U.K.). et al., 1984) . Fig. 1 shows t h a t this differentiation is a c c o m p a n i e d by c h a n g e s in steady state levels of c-ras R N A . A p p r o x i m a t e l y 6 h after a d d i t i o n of R A m a j o r increases in c-ras R N A levels are seen. T h i s increase is not a result of amplification of e n d o g e n o u s cellular genes (data n o t shown). 
RESULTS c-ras R N A increases upon differentiation o f T2 cells

A d d i t i o n of 10 -6 M-RA is k n o w n to result in differentiation of h u m a n t e r a t o c a r c i n o m a cells to a diverse set of s o m a t i c cell types ( T h o m p s o n
Expression of ras in transfected cells results in permissiveness for H C M V infection
Recent reports have shown that murine F9 teratocarcinoma cells can be induced to differentiate with exogenous v-fos (Muller & Wagner, 1984) and v-ras has been implicated in differentiation of rat phaeochromatocytoma cells (Bar-Sagi & Feramisco, 1985) . Consequently we introduced H-ras expression vectors into NT2D1 cells to analyse their effect on these undifferentiated cells, pEJ6.6, a genomic ras clone from T24 bladder carcinoma cells (Shih & Weinberg, 1982) , was introduced into T2 cells by cotransfection with pSV2neo (Southern & Berg, 1982) . Approximately 4 weeks post-transfection cells were analysed for ras expression by immunofluorescence. Fig. 2 clearly shows strong staining of pEJ6.6-transfected cells with the anti-ras serum with no staining of control pSV2neo transfectants. This confirms the expression of exogenous ras in transfected cells.
Undifferentiated T2 cells are non-permissive for HCMV IE gene expression (Gonczol et al., 1984) . Fig. 3(a) shows that the vector pEScat, a CAT expression vector under the control of 2-1 kb of 5' non-coding region of the HCMV major IE gene, is not expressed in T2 cells but results in high levels of CAT expression when introduced into T2 cells induced with RA for 5 days. Similarly a deletion of 1-795 kb of the 5' end of pEScat, resulting in the vector piE lcat term (G. Wilkinson & A. Akrigg, unpublished data; Sinclair, 1987) , permits expression in undifferentiated cells (Fig. 3 a) . MboI digestion and Southern analysis of D N A from transfected cells shows this difference is not due to differential D N A uptake, stabilization or replication (data not shown). This is consistent with undifferentiated cells containing negative factors which repress expression of the HCMV major IE gene by interacting directly or indirectly with upstream control regions, as has been suggested (Nelson et al., 1987) . In contrast, Fig. 3 (Fig. 4b) . EJras-transfected ceils are also permissive for HCMV infection (Fig 4d) .
It is possible that the high levels of expression of the major IE gene in ras-expressing cells can be explained by trans-activation of the HCMV promoter by ras, which has been observed for the polyoma virus enhancer (Wasylyk et al., 1987) , as transient cotransfection of pEJ6.6 with pEScat does lead to small but reproducible up-regulation of CAT expression. Although this level of increased CAT expression is not as high as that observed in cells stably transfected with pEJ6.6 (compare Figs. 3a and 3c) , this could be a result of more of the stably transfected cells expressing higher levels of ras.
Transfection with oncogenic ras induces changes in cell surface markers associated with RA-induced differentiation of T2 ceils
Initial phenotypic changes associated with RA-induced differentiation of T2 cells are alterations in the levels of differentiation-specific cell surface antigens SSEA1 and SSEA3 . Whilst expression of SSEA3 is specific for undifferentiated T2 cells, addition of RA for 5 days results in a reduction of SSEA3 expression and increases the differentiation-specific marker SSEA1, a fucosylated lactosamine . Fig. 5 clearly shows that changes in the level of expression of SSEA1 equivalent to those seen during early times (5 to 7 days) of RA induction of T2 cells do occur in EJras-transfected cells. T2 cells transfected with only pSV2neo show no changes in SSEA1 fluorescence (Fig. 5c ). Exposure of T2 cells to RA for 5 to 7 days eventually leads to a cessation of cell proliferation and terminal differentiation which is not dependent on the continued presence of RA . Three weeks after addition of RA, T2 cells cleary showed reduced proliferation and terminal differentiation (Fig. 6b) . In contrast, E J r a s -t r a n s f e c t e d cells showed no signs of reduced proliferation and failed to undergo terminal differentiation (Fig. 6c) . To date continuous culture of these cells has still shown no sign of terminal differentiation.
DISCUSSION
Human teratocarcinoma cells which respond to RA by differentiation present an excellent system in which to study cellular regulation of HCMV gene expression. The observation that T2 cells are non-permissive for HCMV infection but exposure to RA, which induces differentiation, leads to a lifting of this repression, argues strongly for differentiation-specific cellular factors controlling HCMV gene expression. In agreement with Nelson et al. (1987) , we believe that the inactivity of the HCMV IE promoter is due, at least in part, to negative factors present in undifferentiated T2 cells which interact directly or indirectly with upstream control regions of the major IE gene. This region is known to include specific binding sites for nuclear factor 1 (Hennighausen & Fleckenstein, 1986) .
We have shown that an early event of RA-induced differentiation of T2 cells is the increase in steady state levels of c-ras RNA and that transfection of T2 cells with oncogenic ras results in differentiation and permissiveness for HCMV infection. In some way, expression of oncogenic ras in T2 cells leads to a switch in their usual non-permissive phenotype for HCMV infection and these cells are capable of expressing major IE expression vectors and infection with HCMV results in IE antigen expression. This suggests that expression o f r a s in T2 cells results in changes in the expression of cellular factors which regulate the major controlling genes of HCMV. Similar but transient trans-activation has been shown for the polyoma virus enhancer (Wasylyk et al., 1987) , and it is interesting to note that some transient trans-activation of the HCMV IE enhancer does appear to occur by ras (see Fig. 3c ).
The expression of ras in T2 cells, resulting in permissiveness for HCMV infection, also results in c o n c o m i t a n t changes in differentiation-specific antigens. It does not, however, result in a commitment to full terminal differentiation. This is in contrast to transfection with vectors expressing v-los from FBJ routine osteosarcoma virus which result in T2 cells permissive for HCMV infection and also leads to terminal differentiation (J. H. Sinclair, unpublished observations) as might be expected. The changes in SSEA1 expression in transfected T2 cells suggest that oncogenic ras expression leads to changes in cellular gene expression associated with early events of RA-induced differentiation, but RA-induced changes which eventually lead to reduced cell proliferation and terminal differentiation are not induced by ras in this system. We think it likely that differentiation results in a loss of a cellular repressor of HCMV IE expression, perhaps equivalent to the Ela-like cellular factor observed in mouse teratocarcinoma cells which represses enhancer-dependent transcription (Reichel et al., 1987) . This also occurs upon expression of exogenous ras. To date, ras has been implicated in transformation, the mitogenic response and differentiation of rat phaeochromatocytoma cells (for review, see Ohlsson & Pfeifer-Ohlsson, 1987) . Our observations suggest that ras may also play a role in the in vitro differentiation of human teratocarcinoma cells. However, whether ras plays a direct role in switching on genes required for differentiation or simply removes the need for RA is hard to assess.
The observation that ras expression permits HCMV infection of T2 cells, while resulting in differential cellular gene expression associated only with early events of RA-induced differentiation, is interesting. Clearly, a commitment to terminal differentiation is not a prerequisite for permissiveness for HCMV infection but changes in cellular factors associated with early events along the differentiation pathway of T2 cells appear to be important for expression of HCMV major IE genes and permissive infection.
We believe that manipulation of T2 cells to different levels of differentiation and states of permissiveness for HCMV infection may be a useful approach to analysing factors associated with cellular differentiation that regulate human herpesvirus gene expression.
